Drug development represents a long and expensive process. It involves several stages from target identification to lead discovery and optimisation of the final drug composition, preclinical and clinical trials culminating in approval for clinical use.
Cell-based studies represent an important stage of the drug discovery process.
Moreover, tests using human cells may be more relevant than
Currently, more than half of all studied drugs fail in the second or third phase of clinical trials due to a lack of confirmed efficacy. About third of drugs fail because of safety issues, such as unacceptable toxicity [4]. As attrition rates in drug development remain high, there is an urgent need for improvement of screening methods allowing for better precision and reliable estimation of drug effects. The present review focuses on the existing cell-based methods most frequently used in the study of drugs, taking into account their advantages and drawbacks.
Cytotoxicity is one of the crucial indicators for biological evaluation
dye exclusion (eosin, Trypan blue, erythrosine B, Congo red assays);
colourimetric assays (MTT/MTS, XTT, WST-1, WST-8, LDH, SRB, NRU and crystal violet assays);
fluorometric assays (Alamar Blue/resazurin assay, CFDA-AM);
luminometric assays (ATP assay, real-time viability assay).
Determination of membrane integrity is possible using a dye exclusion assay, which is one of the simplest and widely used methods. Of the dyes listed, Trypan blue has been used the most extensively to assess the percentage of viable cells [5]. After the addition of Trypan blue into cell suspension, viable cells will have a clear cytoplasm, whereas dead cells will have a blue cytoplasm. The number of viable and dead cells per unit volume is determined by light microscopy using hemacytometer [6].
While the staining protocol is quite fast and simple it is difficult to process a large number of samples simultaneously, particularly when the exact timing of progressive cytotoxic effects is taken into consideration. Moreover, Trypan blue staining cannot detect the cells that are alive but losing their metabolic activity. An important disadvantage of Try-pan blue is its toxic side effect on mammalian cells [7]. Additionally, such dyes as Trypan blue are not recommended for use on monolayer cell cultures, as they are designed for cell suspensions. This means that monolayer cells must first be trypsinised.
By contrast, colourimetric assays are applicable for both adherent and suspended cell cultures. MTT assay is a widely used colourimetric method to measure cell death. The reduction of yellow tetrazolium dye (MTT) by mitochondrial dehydrogenase leads to a coloured formazan product accumulation — this process represents an underlying chemical reaction in every tetrazolium based assay [8]. Various organic solvents, such as isopropanol / hydrochloride acid solution might be used to dissolve purple formazan crystals. XTT, MTS, WST-1, and WST-8 assays represent the improved versions of MTT [1]. The final product of the reaction is soluble in water or cell culture medium, however the solubility of these dyes is substantially reduced, and the concentrations of 1–2 mg/ml should be applied instead of 0.2–0.5 mg/ml used in the case of the original MTT [8].
LDH (lactate dehydrogenase) cytotoxicity assay is another colourimetric method of determining cellular cytotoxicity. The assay quantitatively measures the stable, cytosolic LDH, which releases from damaged cells. LDH is an enzyme which is normally located within the cell cytoplasm. Reduced cell viability is associated with increased leakiness of the plasma membrane, allowing for LDH release into the cell culture medium. The released LDH can be measured with a coupled enzymatic reaction resulting in the conversion of a tetrazolium salt (iodonitrotetrazolium) into a red colour formazan by catalyst (diaphorase) [9]. The major limitation of this cytotoxicity assay is that serum used for culture medium supplementation and some other compounds possess inherent LDH activity and cause extremely high background readings. For this reason, LDH assay is limited to serum-free or low-serum culture conditions [2].
Among the various methods used for cell viability and cytotoxicity assessment, resazurin-based assay (Alamar Blue) seems to exhibit all features of an optimal, reliable test - it is one-step, sensitive, non-toxic for cells, and cost-effective [10]. In living cells, resazurin is known to intercept the electrons from the mitochondrial electron transport chain. In this way, non-fluorescent resazurin (blue, oxidised) is being converted to its reduced fluorescent form – resorufin (pink), with an absorption maximum at 601 nm. The metabolic activity of cells is proportional to the amount of produced resorufin. Resazurin has been used extensively in cell proliferation, growth, and toxicity studies of cells types ranging from human to bacterial cells [11]. However, the fact that bacteria are able to reduce resazurin indicates the crucial role of conducting clean, contamination-free cell cultures in obtaining reliable results.
The clonogenic assay has been initially developed for evaluating the impact of ionising radiation on mammalian cell culture [12]. Nowadays, it is commonly used for studying the effects of experimental drugs on tumour cells. The cells are considered clonogenic if they maintain their reproductive ability to proliferate and form a large colony or a clone [13]. The colony formation assay consists of plating a known number of cells, allowing them to settle and grow for 1-3 weeks, fixing and staining them with crystal violet, and counting the cells that formed colonies. The colony is defined to comprise of at least 50 cells. The colonies consisting of cells with damaged nuclei or that are only formed of a small number of cells should be considered non-viable, as they are not able to undergo “unlimited” divisions. The loss of cells’ ability to form the colonies can be related to the antitumor effect of studied agents by a dose-survival curve [14].
The inhibition of cell proliferation can reflect the cytotoxic effect of a studied compound and therefore assessing the proliferation activity is useful when testing the effectiveness of new anti-cancer drugs, as well as the safety of various therapeutic agents [12].
During S phase of the cell cycle genome replication occurs, when DNA polymerases incorporate nucleosides into newly synthesised DNA strands. The process of DNA synthesis is relatively specific for cell division and therefore can be considered a marker of proliferation activity of cells [15]. Nucleoside-analog incorporation assays rely on the introduction of chemically or radioactively labelled nucleosides, which subsequently become incorporated into DNA strands synthesised during S phase. Further analysis allows for the quantitative assessment of proliferation level, based on the amount of labelled nucleoside utilised by cells.
A classic example of the DNA synthesis assay is radioactive tagging with 3H-labeled thymidine (3HT). During this incorporation assay, the excess of radiolabeled thymidine is added to cell samples and allowed to incubate for several days. The measurement of the level of incorporated 3H-T is performed using a liquid scintillation counter. This assay is commonly regarded as reliable and accurate. It can be performed in experiments
Nowadays, the use of radioactive materials is limited, and another protocol which uses 5-bromo-2′-deoxyuridine (BrdU), also a synthetic thymidine analogue, is usually preferred [12]. Incorporated BrdU is detected by BrdU-specific antibody and can be measured as a colourimetric, chemiluminescent or fluorescent signal. This technique is suitable for immunohistochemistry or immunocytochemistry, in-cell ELISA, flow cytometry and high-throughput screening (HTS). Besides avoiding the use of radioactive substances, the advantage of this method is that it can be used not only
Stress reduction assays are aimed to assess the elimination or reduction of the stresses and toxins that cause cell damage. This approach is widely used for studies on drugs for neurodegenerative diseases. For example, in the case of Alzheimer’s disease (AD), the characteristic pathological markers are represented by amyloid plaques consisting of amyloid-beta (Aβ) peptide and neurofibrillary tangles formed by microtubule-associated protein tau (MAPT) [18]. For this reason, phenotypic screens are performed to search for compounds that reduce Aβ or MAPT levels, using an established cell line that overexpresses Aβ or tau protein [19,20]. In the case of Parkinson’s disease (PD), the loss of dopaminergic neurons in
Stress reduction screenings are also useful for searching for compounds with antioxidative and anti-inflammatory effects. Antioxidative properties can be readily assayed in HTS format, measuring the level of reactive oxygen species (ROS) produced by cells or in chemical assays such as DPPH free radical scavenging method [22,23]. However, the chemical assays only provide information about free radical scavenging potential of the studied compounds. In contrast, cell-based approaches allow estimating the balance between the production of ROS in treated cells and the activity of antioxidative cell defence. Additionally, compounds with anti-inflammatory properties can be screened against lipopolysaccharide (LPS)–induced nitric oxide (NO) production, and tumour necrosis factor–α (TNF-α) and interleukin-1β (IL-1β) expression [24].
Drug absorption across biological membranes represents a complex multi-pathway process. Drugs can penetrate cells via different routes [3,25]:
transcellular route:
passively through the cell membrane, actively through carrier-mediation - active or facilitated diffusion, endocytosis,
paracellular route - via the junction connections between the adjacent cells.
Various efflux transporters incorporated into cell membranes, such as P-glycoprotein (P-gp) can limit drug absorption [26]. Some epithelial enzymes are involved in metabolising drugs to alternate compounds, which may be further absorbed. Finally, receptor-mediated endocytosis also contributes to the process of absorption. Among the several pathways the molecules follow to penetrate cell membranes, diffusion via lipid- and carrier-mediated transport is particularly important regarding the pharmacokinetic mechanisms [27]. The preferred pathway for specific drug absorption or transport depends on its physicochemical characteristics as well as the membrane features. In general, lipophilic drugs tend to cross the biological membrane by the transcellular pathway. In contrast, hydrophilic drugs pass the membrane paracellulary through cell junctions, although hydrophilic drugs can also cross via transporters [3].
Quantitative permeation through the cell monolayer can be defined by the permeation coefficient (Pc) [28]:
Pc=V/A x Co x dC/dt [cm/s] where:
V- culture medium volume (cm3),
A - surface area of the membrane (cm2),
Co - initial concentration of the component, where the studied compound was introduced (μg/cm3),
dC/dt - increase of concentration after the compound administration.
Permeability data obtained from different cell models can vary between laboratories, even though good
There are various drug administration site-specific models, such as intestinal, nasal, pulmonary, vaginal, rectal, ocular and skin, that have been established and examined
The blood-brain barrier (BBB) is another example of a complex anatomical and functional structure that must be precisely simulated
In the last decades, most of the current successful BBB
To get reliable results, the
An ideal cell-based culture model would simulate a tissue-specific physiological or disease-specific environment. Such a model would include cell-to-cell contact and cell-to-ECM interactions, as well as tissue-specific stiffness, oxygen, nutrient and metabolic waste product gradients. Most culture techniques currently do not meet all of the above criteria but rather have their own advantages and drawbacks. Thus, it is important to choose the most appropriate cell-based culture model for a specific application in combination with the proper selection of relevant assays. This approach will allow for the estimation of the most significant parameters in the treated cells and obtaining reliable and physiologically relevant results.